Clinical Trials Browser

Uveal Melanoma, Astrocytoma, Carcinoma, Renal Cell, Medulloblastoma, Melanoma, Neoplasms, Wilms Tumor, Neuroblastoma, Neutropenia, Retinoblastoma, Osteosarcoma, Testicular Neoplasms, Thrombocytopenia, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Gestational Trophoblastic Disease

NCT01110486 2013-11-06

ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors

Phase 1 Completed

102 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT00036777 2013-07-01

UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01213381 2013-05-24

Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors

Phase 1 Completed

18 enrolled

Other solid neoplasm

Advance Solid Tumors

NCT00024284 2013-04-05

Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00027898 2013-02-07

Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

27 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00287937 2013-02-07

Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00028561 2013-01-17

BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors

Phase 1 Terminated

45 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00028587 2013-01-16

PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

96 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

Phase 1 Suspended

54 enrolled

GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00502892 2012-08-01

Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors

Phase 1 Completed

2 enrolled

Other solid neoplasm

Solid Tumors

NCT00573690 2012-04-24

Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors

Phase 1 Completed

31 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00520000 2012-03-06

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors

Phase 1 Completed

47 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01159418 2011-09-13

LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors

Phase 1 Unknown

36 enrolled

Other solid neoplasm

Advanced Solid Tumors

Clinical Trials

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

KANDLELIT-001

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)

Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors

HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors

Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies

MK-1775-001

A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors

Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma

M6620 First in Human Study

Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma

Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours

Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors

Ispinesib In Combination With Carboplatin In Patients With Solid Tumors

BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors

Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors

UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors

Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors

Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors

Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors

BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors

PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors

Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors

LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors